Through the 90-day period concluding January 10, 2026, Vertex Pharmaceuticals's top three insider stakeholders include Ceo & President Reshma Kewalramani (115.97K shares), Evp Chief Patient & Ext Af Off Amit Sachdev (68.49K shares), Evp And Coo Stuart A Arbuckle (63.37K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Reshma Kewalramani | Ceo & President | 115,968 | 07 Aug, 2025 |
| Amit Sachdev | Evp Chief Patient & Ext Af Off | 68,490 | 28 Feb, 2025 |
| Stuart A Arbuckle | Evp And Coo | 63,368 | 02 Jul, 2025 |
| Bruce I Sachs | 45,000 | 07 Aug, 2025 | |
| Ourania Tatsis | Evp And Chief Reg. & Quality Off. | 42,293 | 09 Jan, 2026 |
| Charles F Jr Wagner | Evp And Co & Fo | 37,725 | 08 Jan, 2026 |
| Carmen Bozic | Evp And Cmo | 32,669 | 28 Feb, 2025 |
| Bastiano Sanna | Evp And Cell & Genetic Therapies | 32,038 | 09 May, 2023 |
| Jeffrey M Leiden | Executive Chairman | 24,027 | 05 Dec, 2025 |
| David Altshuler | Evp And Chief Scientific Officer | 23,281 | 19 May, 2025 |
| Edward Morrow Iii Atkinson | Evp And Chief Technical Ops. Off. | 16,852 | 19 Nov, 2025 |
| Jonathan Biller | Evp And Chief Legal Officer | 15,306 | 05 Dec, 2025 |
| Joy Liu | Svp And General Counsel | 9,605 | 17 Aug, 2022 |
| Kristen Ambrose | Svp & Chief Accounting Officer | 7,845 | 28 Feb, 2025 |
| Alan M Garber | 6,872 | 05 May, 2025 | |
| Terrence C Kearney | 6,536 | 14 Aug, 2023 | |
| Lloyd Carney | 6,315 | 20 Nov, 2025 | |
| Sangeeta N. Bhatia | 4,565 | 29 Aug, 2025 | |
| Suketu Upadhyay | 2,354 | 05 May, 2025 | |
| Diana Mckenzie | 2,231 | 05 May, 2025 | |
| Nancy Thornberry | 2,035 | 05 May, 2025 | |
| Yuchun Lee | 1,875 | 31 Jan, 2023 | |
| Jennifer Schneider | 1,718 | 05 May, 2025 | |
| Michel Lagarde | 1,132 | 10 Oct, 2023 | |
| Margaret G Mcglynn | 178 | 03 May, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 07 Jan, 2026 | Ourania Tatsis | Common Stock | D | 4,500 | $474.99 | 42,293 | D | S |
| 06 Jan, 2026 | Charles F Jr Wagner | Common Stock | D | 9,532 | $461.00 | 37,725 | D | S |
| 06 Jan, 2026 | Charles F Jr Wagner | Common Stock | A | 9,532 | $189.38 | 47,257 | D | M |
| 04 Dec, 2025 | Jeffrey M Leiden | - | - | 24,027 | D | |||
| 04 Dec, 2025 | Jeffrey M Leiden | Common Stock | A | 1 | $91.05 | 24,027 | D | M |
| 03 Dec, 2025 | Charles F Jr Wagner | Common Stock | D | 7,000 | $461.00 | 37,725 | D | S |
| 03 Dec, 2025 | Charles F Jr Wagner | Common Stock | D | 7,000 | $451.00 | 44,725 | D | S |
| 03 Dec, 2025 | Jeffrey M Leiden | - | - | 67,298 | D | |||
| 03 Dec, 2025 | Jeffrey M Leiden | - | - | 75,197 | D | |||
| 03 Dec, 2025 | Jeffrey M Leiden | - | - | 52,137 | D | |||
| 03 Dec, 2025 | Jeffrey M Leiden | Common Stock | D | 2,469 | $443.21 | 79,549 | D | S |
| 03 Dec, 2025 | Jeffrey M Leiden | - | - | 79,549 | D | |||
| 03 Dec, 2025 | Jeffrey M Leiden | Common Stock | D | 1,152 | $447.05 | 66,146 | D | S |
| 03 Dec, 2025 | Jeffrey M Leiden | - | - | 83,338 | D | |||
| 03 Dec, 2025 | Jeffrey M Leiden | Common Stock | D | 2,070 | $455.22 | 24,026 | D | S |
| 03 Dec, 2025 | Jeffrey M Leiden | - | - | 24,026 | D | |||
| 03 Dec, 2025 | Jeffrey M Leiden | Common Stock | D | 10,360 | $453.34 | 26,096 | D | S |
| 03 Dec, 2025 | Jeffrey M Leiden | - | - | 66,146 | D | |||
| 03 Dec, 2025 | Jeffrey M Leiden | - | - | 36,456 | D | |||
| 03 Dec, 2025 | Jeffrey M Leiden | - | - | 26,096 | D |